Lupus Erythematosus, Systemic: all 1,222 studies
Page 12 of 13. Open to participants first (399), then studies with results posted, then the rest; newest registration first within each.
- Aspirin Resistance in Systemic Lupus Erythematosus (SLE)CompletedNCT00731302Phase 1
- Magnetic Resonance Spectroscopy, Perfusion, and Diffusion Tensor Imaging in Neuropsychiatric LupusCompletedNCT00730002Not applicable
- Magnetic Resonance Spectroscopy, Perfusion and Diffusion Tensor Imaging in Neuropsychiatric LupusCompletedNCT00723671Not applicable
- Study Evaluating The SBI-087 In Subjects With Systemic Lupus ErythematosusCompletedNCT00714116Phase 1
- Mesenchymal Stem Cells Transplantation for Refractory Systemic Lupus Erythematosus (SLE)Status unknownNCT00698191Phase 1/2
- The Systemic Lupus Erythematosus (SLE) Activity Gene Expression (SAGE) StudyStatus unknownNCT00671047
- Steroid Induced Osteoporosis in Patients With Systemic Lupus ErythematosusCompletedNCT00668330Phase 4
- Open-label Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus Patients With Active DiseaseCompletedNCT00660881Phase 2
- A Study to Evaluate Safety and Tolerability of Subcutaneous Doses of MEDI-545 in Subjects With LupusCompletedNCT00657189Phase 2
- Phase 1 Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)CompletedNCT00657007Phase 1
- Leflunomide in Systemic Lupus ErythematosusCompletedNCT00637819Phase 2
- Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) LesionsCompletedNCT00625521Phase 2
- Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions (2)CompletedNCT00625157Phase 2
- Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus (SLE) Patients With Active DiseaseCompletedNCT00624351Phase 2
- Safety Study of Two Vaccine Strategies in Patients With Systemic Lupus ErythematosusCompletedNCT00611663Phase 2/3
- BLYS and IFN in SLECompletedNCT00611611
- Cardiology Prevention in Systemic Lupus Erythematosus (SLE)WithdrawnNCT00610805Not applicable
- Comparing the Therapeutic Efficacy of Pimecrolimus Cream With Betamethasone Cream for Discoid Lupus ErythematosusCompletedNCT00608673Not applicable
- Study to Evaluate the Safety, Tolerability and Short Term Efficacy of Extracorporeal Specific Immunoadsorption LupusorbTM Columns for the Treatment of Systemic Lupus Erythematosus (SLE) PatientsStatus unknownNCT00608127Not applicable
- FolateScan in Autoimmune DiseaseCompletedNCT00588393Phase 2
- Characteristics and Disease Progression of Mixed Connective Tissue Disease and Systemic Lupus ErythematosusCompletedNCT00582881
- Study to Evaluate the Natural History of Osteoporosis in Children and Adolescents With Systemic Lupus ErythematosusCompletedNCT00582465
- Analyzing the Association of Gene Variants With Increased Risk of Coronary Heart Disease in Women With Systemic Lupus ErythematosusCompletedNCT00563082
- Can Targeted Elimination of B-cell Depletion Therapy and/or Combination Therapy on Systemic Lupus ErythematosusCompletedNCT00556192Phase 2
- Insulin Resistance and Atherosclerosis in Women With LupusCompletedNCT00544102
- A Study of rhuMAb IFNalpha in Adults With Systemic Lupus ErythematosusCompletedNCT00541749Phase 1
- Pulse Corticosteroid Therapy and Effect on Brain Water DiffusivityStatus unknownNCT00527176
- Treatment of Cutaneous Lupus Erythematosus (CLE) With the 595 nm Flashlamp Pulsed Dye LaserCompletedNCT00523588Phase 2
- CLUE Study: Connective Tissue Disease Leg Ulcer Etiology StudyCompletedNCT00522002
- Estrogen and Gender Biased AutoimmunityStatus unknownNCT00519454
- Statins and Lupus: Effects of Statins on Clinical Lupus Parameters, Serological Markers and Toll-like ReceptorsCompletedNCT00519363Phase 1/2
- Duke Autoimmunity in Pregnancy RegistryCompletedNCT00513591
- The Efficacy and Safety of Calcitriol for the Treatment of Lupus Nephritis and Persistent ProteinuriaWithdrawnNCT00508898Phase 4
- Myfortic Versus Azathioprine in Systemic Lupus ErythematosusTerminatedNCT00504244Phase 3
- Feasibility and Safety of Acupuncture for Systemic LupusCompletedNCT00493753Not applicable
- Effects of Treatment of Chronic Stress in Patients With LupusCompletedNCT00483613Not applicable
- A Study to Evaluate the Safety and Tolerability of Multiple Intravenous Doses of MEDI 545 in Patients With Systemic Lupus ErythematosusCompletedNCT00482989Phase 1
- Study of TRU-015 in Subjects With Membranous Nephropathy Secondary to Systemic Lupus ErythematosusTerminatedNCT00479622Phase 1
- Study of Methotrexate in Lupus ErythematosusCompletedNCT00470522Phase 3
- Preventive IVIG Therapy for Congenital Heart BlockCompletedNCT00460928Early Phase 1
- Cyclophosphamide in Lupus NephritisStatus unknownNCT00441220
- An Open Labeled Pilot Study of Atorvastatin in Systemic Lupus ErythematosusStatus unknownNCT00432354Phase 2/3
- Interdisciplinary Study Group of Lupus Erythematosus (ISGLE)CompletedNCT00420173
- European Society of Cutaneous Lupus Erythematosus (EUSCLE)Status unknownNCT00420121
- Vitamin D Therapy in Patients With Systemic Lupus Erythematosus (SLE)CompletedNCT00418587Phase 1
- Efficacy of Faslodex in Treatment of SLE Clinical, Serologic, and Molecular StudiesCompletedNCT00417430Phase 2
- The Reduction of Systemic Lupus Erythematosus Flares :Study PLUSCompletedNCT00413361Phase 4
- Abnormalities of B Lymphocytes During Systemic LupusCompletedNCT00401141Not applicable
- Effect of Hormone Replacement Therapy on Lupus ActivityCompletedNCT00392093Phase 4
- Dehydroepiandrosterone Administration in Women With Systemic Lupus Erythematosus or Primary Sjögren's SyndromeCompletedNCT00391924Phase 2
- Study of LJP 394 (Abetimus Sodium) in Lupus PatientsWithdrawnNCT00390091Phase 2
- Study of Epratuzumab in Systemic Lupus ErythematosusCompletedNCT00383513Phase 2
- Study of Epratuzumab in Systemic Lupus Erythematosus (SLE)TerminatedNCT00383214Phase 3
- Study of Epratuzumab in Systemic Lupus ErythematosusWithdrawnNCT00382837Phase 3
- Aspirin and Statins for Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus ErythematosusCompletedNCT00371501Phase 4
- TNF Blockade With Remicade in Active Lupus Nephritis WHO Class V (TRIAL )TerminatedNCT00368264Phase 2/3
- Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) StudyCompletedNCT00342095
- Five-Year Actively Controlled Clinical Trial in New Onset Juvenile Systemic Lupus Erythematosus NephritisWithdrawnNCT00336414Phase 3
- Allogeneic Blood Stem Cell Transplantation for Patients With Life-Threatening Systemic Lupus ErythematosusTerminatedNCT00325741Phase 1
- Efficacy of Topical Tacrolimus in Different Subtypes With Cutaneous Lupus Erythematosus (CLE)CompletedNCT00317681Phase 2
- Safety and Tolerability of MEDI-545 in Patients Who Have Systemic Lupus Erythematosus (SLE)CompletedNCT00299819Phase 1
- Memory and Attention Problems in Lupus: New Treatment Trial With ModafinilTerminatedNCT00297284Not applicable
- Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and VasculitisCompletedNCT00293072Phase 2
- Health-related Quality of Life Measure in Pediatric LupusCompletedNCT00280137
- Allogeneic Stem Cell Transplantation in Systemic Lupus ErythematosusWithdrawnNCT00278590Phase 1
- Immune Ablation and Hematopoietic Stem Cell Support in Patients With Systemic Lupus Erythematosus: A Phase II StudyCompletedNCT00271934Phase 2
- Genetic Study of Lupus Patients and Their FamiliesCompletedNCT00235378
- Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST)WithdrawnNCT00230035Phase 2
- Cutaneous Lupus Erythematosus and ElidelWithdrawnNCT00222183Not applicable
- A Study to Evaluate the Tolerability, Safety and Effectiveness of Edratide in the Treatment of LupusTerminatedNCT00203151Phase 2
- Dehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary Artery Disease (CAD) PreventionCompletedNCT00189124Phase 2/3
- HIPP Learning to Live Better With Lupus: The Health Improvement and Prevention Program in Systemic Lupus ErythematosusStatus unknownNCT00188357Not applicable
- Study of Endothelial Dysfunction in Systemic Lupus and Its Role in Heart DiseaseStatus unknownNCT00188188Phase 4
- Memantine in Systemic Lupus ErythematosusCompletedNCT00181298Not applicable
- Decoy Receptor 3 (DcR3) Polymorphisms in Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE)Status unknownNCT00172666
- Skin Denervation in Systemic Lupus ErythematosusCompletedNCT00155532Phase 1
- Physical Therapy for Systemic Lupus Erythematosus (SLE)TerminatedNCT00152555Not applicable
- Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous NephritisCompletedNCT00125307Phase 4
- Lupus Atherosclerosis Prevention StudyCompletedNCT00120887Phase 4
- Pharmacokinetics Study of Epratuzumab in Systemic Lupus Erythematosus (SLE)TerminatedNCT00113971Phase 2
- Study of Epratuzumab in Systemic Lupus ErythematosusTerminatedNCT00111306Phase 3
- Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077)CompletedNCT00094380Phase 1/2
- Study of LJP 394 in Lupus Patients With History of Renal DiseaseTerminatedNCT00089804Phase 3
- GL701 (Prestara™) in Women With Systemic Lupus Erythematosus Receiving Treatment With GlucocorticoidsCompletedNCT00082511Phase 3
- The Research Registry for Neonatal LupusCompletedNCT00074373
- Lupus Genetics StudiesCompletedNCT00071175
- Health Beliefs and Health Behaviors Among Minorities With Rheumatic DiseasesCompletedNCT00069342
- Study of Families With Twins or Siblings Discordant for Rheumatic DisordersCompletedNCT00055055
- Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE)CompletedNCT00054938Phase 2
- To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With GlucocorticoidsStatus unknownNCT00053560Phase 3
- Monoclonal Antibody Treatment for Systemic Lupus ErythematosusCompletedNCT00046774Phase 1
- Role of Antibodies in Cognitive Dysfunction in Patients With Systemic Lupus ErythematosusCompletedNCT00042523
- Study of GL701 in Men With Systemic Lupus ErythematosusStatus unknownNCT00037128Phase 3
- Anti-CD20 in Systemic Lupus ErythematosusCompletedNCT00036491Phase 1/2
- Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney DiseaseCompletedNCT00035308Phase 3
- Positron Emission Tomography (PET) to Locate Areas of White Blood Cell ActivityCompletedNCT00029926
- Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye SyndromeCompletedNCT00025818Phase 3
- Phase I Study of Immune Ablation and CD34+ Peripheral Blood Stem Cell Support in Patients With Systemic Lupus ErythematosusStatus unknownNCT00017641Phase 1
- Humanized LL2IGG to Treat Systemic Lupus ErythematosusCompletedNCT00011908Phase 1
- Pilot Study of Cyclophosphamide in Patients With Life-Threatening Systemic Lupus Erythematosus or Antiphospholipid Antibody SyndromeCompletedNCT00010400Not applicable